LXRX
LEXICON PHARMACEUTICALS, INC.
Company overview
- Market capitalization
- $845.42M
- Employees
- 81
- Latest publication
- 2026-09-29
About LEXICON PHARMACEUTICALS, INC.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 21,102,000USD | 5,493,000USD | 14,182,000USD | 28,866,000USD | 1,262,000USD | 1,750,000USD | 1,647,000USD | 1,130,000USD |
| Cost Of Revenue | 108,000USD | 319,000USD | 10,000USD | 209,000USD | 30,000USD | 71,000USD | 166,000USD | 175,000USD |
| Gross Profit | 20,994,000USD | 5,174,000USD | 14,172,000USD | 28,657,000USD | 1,232,000USD | 1,679,000USD | 1,481,000USD | 955,000USD |
| Research Development | 12,756,000USD | 11,197,000USD | 18,757,000USD | 15,571,000USD | 15,303,000USD | 25,780,000USD | 17,643,000USD | 14,228,000USD |
| Selling General Administrative | 9,234,000USD | 8,757,000USD | 7,602,000USD | 9,350,000USD | 11,608,000USD | 39,592,000USD | 39,192,000USD | 32,060,000USD |
| Total Operating Expenses | 21,990,000USD | 19,954,000USD | 26,359,000USD | 24,921,000USD | 26,911,000USD | 65,372,000USD | 56,835,000USD | 46,288,000USD |
| Operating Income | -996,000USD | -14,780,000USD | -12,187,000USD | 3,736,000USD | -25,679,000USD | -63,693,000USD | -55,354,000USD | -45,333,000USD |
| Interest Income | 1,543,000USD | 1,281,000USD | 1,573,000USD | 1,834,000USD | 2,219,000USD | 3,444,000USD | 4,136,000USD | 1,884,000USD |
| Interest Expense | 1,590,000USD | 2,031,000USD | 2,155,000USD | 2,318,000USD | 1,835,000USD | 4,562,000USD | 2,211,000USD | 4,948,000USD |
| Net Interest Income | -47,000USD | -750,000USD | -582,000USD | -484,000USD | 384,000USD | -1,118,000USD | 1,925,000USD | -3,064,000USD |
| Income Before Tax | -1,043,000USD | -15,530,000USD | -12,769,000USD | 3,252,000USD | -25,295,000USD | -64,811,000USD | -53,429,000USD | -48,397,000USD |
| Net Income | -1,043,000USD | -15,530,000USD | -12,769,000USD | 3,252,000USD | -25,295,000USD | -64,811,000USD | -53,429,000USD | -48,397,000USD |
| Net Income From Continuing Ops | -1,043,000USD | -15,530,000USD | -12,769,000USD | 3,252,000USD | -25,295,000USD | -64,811,000USD | -53,429,000USD | -48,397,000USD |
| Ebit | 547,000USD | -13,499,000USD | -10,614,000USD | 5,570,000USD | -23,460,000USD | -60,249,000USD | -51,218,000USD | -44,597,000USD |
| Ebitda | 657,000USD | -13,381,000USD | -10,463,000USD | 5,746,000USD | -23,284,000USD | -60,123,000USD | -51,079,000USD | -44,453,000USD |
| Depreciation And Amortization | 110,000USD | 118,000USD | 151,000USD | 176,000USD | 176,000USD | 126,000USD | 139,000USD | 144,000USD |
| Reconciled Depreciation | 110,000USD | 118,000USD | 151,000USD | 176,000USD | 176,000USD | 126,000USD | 139,000USD | 144,000USD |
| Total Other Income Expense Net | -47,000USD | -750,000USD | -582,000USD | -484,000USD | 384,000USD | -1,118,000USD | 1,925,000USD | -3,064,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | 100,724USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20102010-12-31 · USD | FY 20082008-12-31 · USD | FY 20032003-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 49,803,000USD | 322,073,000USD | 90,335,000USD | 22,854,000USD | 2,222,000USD | 4,908,000USD | 32,321,000USD | 42,838,000USD |
| Cost Of Revenue | 274,000USD | 3,231,000USD | 1,899,000USD | 89,279,000USD | 89,682,000USD | 91,622,000USD | 120,927,000USD | 94,016,000USD |
| Gross Profit | 49,529,000USD | 318,842,000USD | 88,436,000USD | -66,425,000USD | -87,460,000USD | 4,908,000USD | 32,321,000USD | 42,838,000USD |
| Research Development | 61,121,000USD | 91,924,000USD | 156,813,000USD | 89,279,000USD | 89,682,000USD | 75,350,000USD | 108,575,000USD | 82,198,000USD |
| Selling General Administrative | 37,319,000USD | 56,835,000USD | 66,203,000USD | 19,411,000USD | 17,121,000USD | 22,566,000USD | 20,281,000USD | 23,233,000USD |
| Total Operating Expenses | 98,440,000USD | 177,397,000USD | 223,016,000USD | 108,690,000USD | 106,803,000USD | 100,626,000USD | 128,856,000USD | 105,431,000USD |
| Operating Income | -48,911,000USD | 141,445,000USD | -136,681,000USD | -100,366,000USD | -102,371,000USD | -95,718,000USD | -96,535,000USD | -62,593,000USD |
| Interest Income | 6,909,000USD | 3,350,000USD | 1,954,000USD | — | — | — | — | — |
| Interest Expense | 8,339,000USD | 20,676,000USD | 6,984,000USD | 2,253,000USD | 1,971,000USD | 2,719,000USD | 2,691,000USD | 325,000USD |
| Net Interest Income | -1,430,000USD | -17,326,000USD | -5,030,000USD | — | — | — | — | — |
| Income Before Tax | -50,341,000USD | 124,119,000USD | -141,711,000USD | -100,364,000USD | -104,126,000USD | -101,801,000USD | -96,884,000USD | — |
| Net Income | -50,341,000USD | 130,133,000USD | -129,050,000USD | -100,294,000USD | -104,126,000USD | -101,775,000USD | -76,860,000USD | -64,198,000USD |
| Net Income From Continuing Ops | -50,341,000USD | 130,133,000USD | -129,050,000USD | -100,294,000USD | -104,126,000USD | — | — | — |
| Ebit | -42,002,000USD | 144,795,000USD | -128,670,000USD | -98,111,000USD | -102,155,000USD | -99,082,000USD | -96,334,000USD | -62,593,000USD |
| Ebitda | -41,381,000USD | 148,449,000USD | -125,271,000USD | -96,183,000USD | -99,292,000USD | -93,688,000USD | -86,264,000USD | -41,063,000USD |
| Depreciation And Amortization | 621,000USD | 3,654,000USD | 3,399,000USD | 1,928,000USD | 2,863,000USD | 5,394,000USD | 10,070,000USD | 21,530,000USD |
| Reconciled Depreciation | 621,000USD | 3,654,000USD | 3,399,000USD | — | — | — | — | — |
| Total Other Income Expense Net | -1,430,000USD | -17,326,000USD | -5,030,000USD | 2,000USD | -1,755,000USD | -6,083,000USD | -349,000USD | — |
| Unclassified Operating Expenses | — | 28,638,000USD | — | — | — | 2,710,000USD | — | — |
| Income Tax Expense | — | -6,014,000USD | -12,661,000USD | -70,000USD | -833,000USD | -26,000USD | -19,675,000USD | 1,605,000USD |
| Tax Provision | — | -6,014,000USD | -12,661,000USD | -70,000USD | — | — | — | — |
| Non Operating Income Net Other | — | 3,350,000USD | 1,954,000USD | 2,255,000USD | 216,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | 130,133,000USD | -129,050,000USD | -100,294,000USD | -104,126,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 268,819,000USD | 184,987,000USD | 205,927,000USD | 225,583,000USD | 297,671,000USD | 298,420,000USD | 321,123,000USD | 373,356,000USD |
| Other Current Assets | 3,319,000USD | 3,000,000USD | 4,085,000USD | 3,726,000USD | 3,319,000USD | 4,532,000USD | 6,706,000USD | 7,675,000USD |
| Total Liab | 65,963,000USD | 77,449,000USD | 85,768,000USD | 96,143,000USD | 174,639,000USD | 152,470,000USD | 142,611,000USD | 133,376,000USD |
| Total Stockholder Equity | 202,856,000USD | 107,538,000USD | 120,159,000USD | 129,440,000USD | 123,032,000USD | 145,950,000USD | 178,512,000USD | 239,980,000USD |
| Other Current Liab | 5,260,000USD | 11,547,000USD | 11,978,000USD | 10,572,000USD | 11,904,000USD | 29,272,000USD | 20,544,000USD | 14,365,000USD |
| Common Stock | 426,000USD | 366,000USD | 366,000USD | 366,000USD | 366,000USD | 363,000USD | 363,000USD | 363,000USD |
| Capital Stock | 430,000USD | 366,000USD | 366,000USD | 366,000USD | 366,000USD | 363,000USD | 363,000USD | 363,000USD |
| Retained Earnings | -2,018,626,000USD | -2,017,583,000USD | -2,002,054,000USD | -1,989,285,000USD | -1,992,537,000USD | -1,967,242,000USD | -1,933,476,000USD | -1,868,665,000USD |
| Good Will | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD |
| Cash | 38,089,000USD | 34,326,000USD | 49,656,000USD | 21,364,000USD | 62,888,000USD | 66,656,000USD | 34,551,000USD | 35,617,000USD |
| Cash And Short Term Investments | 170,658,000USD | 96,230,000USD | 115,950,000USD | 139,007,000USD | 194,839,000USD | 237,957,000USD | 258,369,000USD | 309,964,000USD |
| Total Current Assets | 186,032,000USD | 101,895,000USD | 122,527,000USD | 145,084,000USD | 245,806,000USD | 246,193,000USD | 268,606,000USD | 320,844,000USD |
| Total Current Liabilities | 9,898,000USD | 20,867,000USD | 21,720,000USD | 34,836,000USD | 110,693,000USD | 45,248,000USD | 36,046,000USD | 27,876,000USD |
| Net Debt | 19,618,000USD | 27,911,000USD | 15,289,000USD | 40,087,000USD | 43,375,000USD | 41,741,000USD | 71,322,000USD | 70,059,000USD |
| Short Term Debt | 1,642,000USD | 6,237,000USD | 1,642,000USD | 909,000USD | 43,100,000USD | 1,175,000USD | 1,301,000USD | 1,291,000USD |
| Short Long Term Debt Total | 57,707,000USD | 62,237,000USD | 64,945,000USD | 61,451,000USD | 106,263,000USD | 108,397,000USD | 105,873,000USD | 105,676,000USD |
| Long Term Debt | 49,684,000USD | 49,408,000USD | 56,508,000USD | 56,107,000USD | 58,643,000USD | 100,298,000USD | 99,895,000USD | 99,499,000USD |
| Short Term Investments | 132,569,000USD | 61,904,000USD | 66,294,000USD | 117,643,000USD | 131,951,000USD | 171,301,000USD | 223,818,000USD | 274,347,000USD |
| Net Receivables | 11,779,000USD | 2,384,000USD | 2,334,000USD | 2,183,000USD | 47,447,000USD | 3,473,000USD | 2,895,000USD | 2,620,000USD |
| Inventory | 276,000USD | 281,000USD | 158,000USD | 168,000USD | 201,000USD | 231,000USD | 636,000USD | 585,000USD |
| Accounts Payable | 2,996,000USD | 3,083,000USD | 3,797,000USD | 5,899,000USD | 10,689,000USD | 14,801,000USD | 14,201,000USD | 12,220,000USD |
| Property Plant Equipment Net | 8,876,000USD | 9,181,000USD | 9,489,000USD | 6,588,000USD | 6,954,000USD | 7,316,000USD | 7,146,000USD | 7,141,000USD |
| Property Plant Equipment Gross | 11,693,000USD | 11,888,000USD | 12,078,000USD | 9,026,000USD | 9,216,000USD | 9,402,000USD | 9,107,000USD | 8,976,000USD |
| Accumulated Other Comprehensive Income | -130,000USD | 30,000USD | 29,000USD | -14,000USD | 25,000USD | 119,000USD | 349,000USD | -193,000USD |
| Common Stock Shares Outstanding | 400,240,000shares | 363,428,000shares | 363,399,000shares | 363,570,000shares | 362,073,000shares | 361,492,000shares | 361,492,000shares | 310,836,000shares |
| Non Current Assets Total | 82,787,000USD | 83,092,000USD | 83,400,000USD | 80,499,000USD | 51,865,000USD | 52,227,000USD | 52,517,000USD | 52,512,000USD |
| Non Current Liabilities Total | 56,065,000USD | 56,582,000USD | 64,048,000USD | 61,307,000USD | 63,946,000USD | 107,222,000USD | 106,565,000USD | 105,500,000USD |
| Non Currrent Assets Other | 29,368,000USD | 29,368,000USD | 29,368,000USD | 29,368,000USD | 368,000USD | 368,000USD | 828,000USD | 828,000USD |
| Net Working Capital | 176,134,000USD | 81,028,000USD | 100,807,000USD | 110,248,000USD | 135,113,000USD | 200,945,000USD | 232,560,000USD | 292,968,000USD |
| Unclassified Non Current Liabilities | 6,381,000USD | 7,174,000USD | — | — | — | 6,924,000USD | — | — |
| Unclassified Equity | 2,220,756,000USD | 2,124,359,000USD | 2,121,452,000USD | 2,118,007,000USD | 2,114,812,000USD | 2,112,347,000USD | 2,110,913,000USD | 2,108,112,000USD |
| Short Long Term Debt | — | 4,595,000USD | — | — | 42,056,000USD | — | — | — |
| Unclassified Current Liabilities | — | -4,595,000USD | — | — | -42,056,000USD | — | — | — |
| Current Deferred Revenue | — | — | 4,303,000USD | 17,456,000USD | 45,000,000USD | — | — | — |
| Non Current Liabilities Other | — | — | 7,540,000USD | 5,200,000USD | 5,303,000USD | — | 6,670,000USD | 6,001,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 184,987,000USD | 298,420,000USD | 229,429,000USD | 194,299,000USD | 136,909,000USD | 203,788,000USD | 417,715,000USD | 284,136,000USD |
| Other Current Assets | 3,000,000USD | 4,532,000USD | 5,130,000USD | 2,481,000USD | 2,164,000USD | 5,049,000USD | 5,320,000USD | 5,336,000USD |
| Total Liab | 77,449,000USD | 152,470,000USD | 136,319,000USD | 77,175,000USD | 23,314,000USD | 47,417,000USD | 300,614,000USD | 310,541,000USD |
| Total Stockholder Equity | 107,538,000USD | 145,950,000USD | 93,110,000USD | 117,124,000USD | 113,595,000USD | 156,371,000USD | 117,101,000USD | -1,471,577,000USD |
| Other Current Liab | 11,547,000USD | 29,272,000USD | 15,866,000USD | 11,486,000USD | 11,883,000USD | 29,138,000USD | 41,598,000USD | 20,189,000USD |
| Common Stock | 366,000USD | 363,000USD | 245,000USD | 189,000USD | 150,000USD | 142,000USD | 106,000USD | 106,000USD |
| Capital Stock | 366,000USD | 363,000USD | 245,000USD | 189,000USD | 150,000USD | 142,000USD | 106,000USD | 106,000USD |
| Retained Earnings | -2,017,583,000USD | -1,967,242,000USD | -1,766,839,000USD | -1,589,720,000USD | -1,487,776,000USD | -1,400,018,000USD | -1,341,444,000USD | -1,471,577,000USD |
| Good Will | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD | 44,543,000USD |
| Cash | 34,326,000USD | 66,656,000USD | 22,465,000USD | 46,345,000USD | 64,065,000USD | 126,263,000USD | 36,112,000USD | 160,052,000USD |
| Cash And Short Term Investments | 96,230,000USD | 237,957,000USD | 170,026,000USD | 138,357,000USD | 86,743,000USD | 152,275,000USD | 271,659,000USD | 160,052,000USD |
| Total Current Assets | 101,895,000USD | 246,193,000USD | 176,547,000USD | 140,866,000USD | 88,921,000USD | 157,719,000USD | 337,754,000USD | 173,324,000USD |
| Total Current Liabilities | 20,867,000USD | 45,248,000USD | 31,546,000USD | 23,172,000USD | 22,124,000USD | 46,806,000USD | 65,341,000USD | 36,751,000USD |
| Net Debt | 27,911,000USD | 41,741,000USD | 83,599,000USD | 8,949,000USD | -61,786,000USD | -113,453,000USD | 210,726,000USD | 84,950,000USD |
| Short Term Debt | 6,237,000USD | 1,175,000USD | 1,291,000USD | 1,291,000USD | 1,089,000USD | 12,199,000USD | 11,565,000USD | -14,423,000USD |
| Short Long Term Debt | 4,595,000USD | — | — | — | — | 11,646,000USD | 11,012,000USD | 1,115,000USD |
| Short Long Term Debt Total | 62,237,000USD | 108,397,000USD | 106,064,000USD | 55,294,000USD | 2,279,000USD | 12,810,000USD | 246,838,000USD | 245,002,000USD |
| Long Term Debt | 49,408,000USD | 100,298,000USD | 99,508,000USD | 48,579,000USD | — | — | 234,171,000USD | 243,887,000USD |
| Short Term Investments | 61,904,000USD | 171,301,000USD | 147,561,000USD | 92,012,000USD | 22,678,000USD | 26,012,000USD | 235,547,000USD | 79,666,000USD |
| Net Receivables | 2,384,000USD | 3,473,000USD | 1,010,000USD | 28,000USD | 14,000USD | 395,000USD | 56,532,000USD | 5,924,000USD |
| Inventory | 281,000USD | 231,000USD | 381,000USD | 0USD | — | 1USD | 4,243,000USD | 4,680,000USD |
| Accounts Payable | 3,083,000USD | 14,801,000USD | 14,389,000USD | 10,395,000USD | 9,152,000USD | 5,469,000USD | 12,178,000USD | 12,052,000USD |
| Property Plant Equipment Net | 9,181,000USD | 7,316,000USD | 7,511,000USD | 8,478,000USD | 3,445,000USD | 295,000USD | 14,047,000USD | 15,865,000USD |
| Property Plant Equipment Gross | 11,888,000USD | 9,402,000USD | 12,049,000USD | 12,874,000USD | 6,029,000USD | 295,000USD | 14,047,000USD | 15,865,000USD |
| Accumulated Other Comprehensive Income | 30,000USD | 119,000USD | 31,000USD | -428,000USD | -10,000USD | -6,000USD | 84,000USD | -12,000USD |
| Common Stock Shares Outstanding | 363,053,000shares | 320,031,000shares | 221,130,000shares | 165,733,000shares | 145,652,000shares | 110,841,000shares | 116,747,000shares | 105,830,000shares |
| Non Current Assets Total | 83,092,000USD | 52,227,000USD | 52,882,000USD | 53,433,000USD | 47,988,000USD | 46,069,000USD | 79,961,000USD | 110,812,000USD |
| Non Current Liabilities Total | 56,582,000USD | 107,222,000USD | 104,773,000USD | 54,003,000USD | 1,190,000USD | 611,000USD | 235,273,000USD | 273,790,000USD |
| Non Currrent Assets Other | 29,368,000USD | 368,000USD | 828,000USD | 412,000USD | 2,269,000USD | 1,231,000USD | 1,655,000USD | 285,000USD |
| Net Working Capital | 81,028,000USD | 200,945,000USD | 145,001,000USD | 117,694,000USD | 66,797,000USD | 110,913,000USD | 272,413,000USD | 136,573,000USD |
| Unclassified Current Liabilities | -4,595,000USD | — | — | — | — | -39,808,000USD | -11,012,000USD | — |
| Unclassified Non Current Liabilities | 7,174,000USD | 6,924,000USD | 5,265,000USD | — | -23,314,000USD | -35,771,000USD | -55,431,000USD | -29,903,000USD |
| Unclassified Equity | 2,124,359,000USD | 2,112,347,000USD | 1,859,428,000USD | 1,708,955,000USD | 1,608,599,000USD | 1,560,954,000USD | 1,462,066,000USD | — |
| Treasury Stock | — | — | — | -2,061,000USD | -7,518,000USD | -4,843,000USD | -3,817,000USD | -2,876,000USD |
| Non Current Liabilities Other | — | — | — | 5,424,000USD | 1,190,000USD | 611,000USD | 1,102,000USD | 238,000USD |
| Net Tangible Assets | — | — | — | 72,581,000USD | 69,052,000USD | 111,828,000USD | 52,842,000USD | -121,067,000USD |
| Other Liab | — | — | — | — | 23,314,000USD | 35,771,000USD | 55,431,000USD | 29,903,000USD |
| Other Assets | — | — | — | — | 136,909,000USD | 1,231,000USD | -45,000USD | 285,000USD |
| Unclassified Non Current Assets | — | — | — | — | -139,178,000USD | -1,231,000USD | — | — |
| Current Deferred Revenue | — | — | — | — | — | 28,162,000USD | — | 3,395,000USD |
| Intangible Assets | — | — | — | — | — | — | 19,716,000USD | 50,119,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 29,665,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -82,334,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,042,999USD | -15,530,000USD | -12,769,000USD | 3,252,000USD | -25,295,000USD | -33,766,000USD | -64,811,000USD | -53,429,000USD |
| Depreciation | 110,000USD | 118,000USD | 151,000USD | 176,000USD | 176,000USD | 125,000USD | 126,000USD | 139,000USD |
| Stock Based Compensation | 3,078,000USD | 2,835,000USD | 3,444,000USD | 3,195,000USD | 3,043,000USD | 1,537,000USD | 2,801,000USD | 4,859,000USD |
| Other Non Cash Items | -462,000USD | -108,000USD | 3,097,000USD | -833,000USD | -2,465,000USD | -1,155,000USD | -1,425,000USD | -4,359,000USD |
| Change To Account Receivables | -9,395,000USD | -50,000USD | -151,000USD | 264,000USD | 1,026,000USD | -578,000USD | -275,000USD | -1,094,000USD |
| Change To Inventory | 5,000USD | -123,000USD | 10,000USD | 33,000USD | 30,000USD | 405,000USD | -51,000USD | -71,000USD |
| Change In Working Capital | -16,413,000USD | -4,548,000USD | -14,312,000USD | 11,203,000USD | -19,237,000USD | 11,768,000USD | 9,690,000USD | 4,250,000USD |
| Total Cash From Operating Activities | -14,730,000USD | -17,233,000USD | -23,833,000USD | 16,993,000USD | -43,778,000USD | -21,491,000USD | -53,619,000USD | -48,540,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -474,000USD | -307,000USD | -250,000USD |
| Free Cash Flow | -14,730,000USD | -17,233,000USD | -23,833,000USD | 16,993,000USD | -43,778,000USD | -21,965,000USD | -53,926,000USD | -48,790,000USD |
| Investments | -70,263,000USD | 4,830,000USD | 52,125,000USD | 15,483,000USD | 40,582,000USD | 53,700,000USD | 53,469,000USD | -12,323,000USD |
| Total Cashflows From Investing Activities | -70,263,000USD | 4,830,000USD | 52,125,000USD | 15,483,000USD | 40,582,000USD | 53,700,000USD | 53,469,000USD | -12,323,000USD |
| Net Borrowings | -5,000,000USD | -3,000,000USD | 0USD | -45,000,000USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | 88,756,000USD | -2,927,000USD | 0USD | -45,000,000USD | -572,000USD | -104,000USD | -916,000USD | -14,000USD |
| Issuance Of Capital Stock | 96,599,000USD | 0USD | 0USD | 0USD | 0USD | -167,000USD | -10,000USD | -14,000USD |
| Change In Cash | 3,763,000USD | -15,330,000USD | 28,292,000USD | -12,524,000USD | -3,768,000USD | 32,105,000USD | -1,066,000USD | -60,877,000USD |
| Begin Period Cash Flow | 34,326,000USD | 78,656,000USD | 21,364,000USD | 62,888,000USD | 66,656,000USD | 34,551,000USD | 35,617,000USD | 96,494,000USD |
| End Period Cash Flow | 38,089,000USD | 63,326,000USD | 49,656,000USD | 50,364,000USD | 62,888,000USD | 66,656,000USD | 34,551,000USD | 35,617,000USD |
| Other Cashflows From Financing Activities | -2,843,000USD | -2,927,000USD | 572,000USD | -45,000,000USD | -572,000USD | -15,000USD | -906,000USD | -15,000USD |
| Sale Purchase Of Stock | — | 0USD | — | — | — | 0USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | 440,000USD | -52,125,000USD | 1,214,000USD | 1,326,000USD | — | 7,418,000USD | — |
| Unclassified Financing Cash Flow | — | 3,000,000USD | — | 45,000,000USD | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | -3,444,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | 52,125,000USD | -1,214,000USD | -1,326,000USD | — | -7,111,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -50,341,000USD | -200,403,000USD | -177,119,000USD | -101,944,000USD | -87,758,000USD | -58,574,000USD | 130,133,000USD | -120,548,000USD |
| Depreciation | 621,000USD | 534,000USD | 554,000USD | 427,000USD | 292,000USD | 2,934,000USD | 3,654,000USD | 3,683,000USD |
| Stock Based Compensation | 12,517,000USD | 13,499,000USD | 14,340,000USD | 11,520,000USD | 10,577,000USD | 13,274,000USD | 14,218,000USD | 11,696,000USD |
| Other Non Cash Items | -3,754,000USD | -6,648,000USD | -2,331,000USD | 744,000USD | 54,000USD | -131,572,000USD | 30,103,000USD | 1,336,000USD |
| Change To Account Receivables | 1,089,000USD | -2,463,000USD | -982,000USD | -14,000USD | 381,000USD | 53,227,000USD | -50,608,000USD | -1,099,000USD |
| Change To Inventory | -50,000USD | 150,000USD | -381,000USD | -172,000USD | 0USD | 345,000USD | 437,000USD | -2,732,000USD |
| Change In Working Capital | -26,894,000USD | 14,238,000USD | 2,659,000USD | 402,000USD | -10,231,000USD | 31,079,000USD | -58,287,000USD | -44,774,000USD |
| Total Cash From Operating Activities | -67,851,000USD | -178,780,000USD | -161,897,000USD | -88,851,000USD | -87,017,000USD | -142,969,000USD | 113,807,000USD | -148,607,000USD |
| Capital Expenditures | 0USD | -1,031,000USD | -470,000USD | -1,326,000USD | -1,221,000USD | -87,000USD | -70,000USD | -95,000USD |
| Free Cash Flow | -67,851,000USD | -179,811,000USD | -162,367,000USD | -90,177,000USD | -88,238,000USD | -143,056,000USD | 113,737,000USD | -148,702,000USD |
| Investments | 113,020,000USD | -15,378,000USD | -77,667,000USD | -69,752,000USD | 3,331,000USD | 209,445,000USD | -155,785,000USD | 169,671,000USD |
| Total Cashflows From Investing Activities | 113,020,000USD | -15,378,000USD | -49,943,000USD | -71,078,000USD | 2,110,000USD | 380,756,000USD | -155,855,000USD | 169,576,000USD |
| Net Borrowings | -48,000,000USD | 0USD | 49,961,000USD | 48,868,000USD | -11,700,000USD | -216,580,000USD | -1,285,000USD | -2,004,000USD |
| Total Cash From Financing Activities | -48,499,000USD | 238,349,000USD | 187,960,000USD | 142,209,000USD | 22,709,000USD | -147,636,000USD | -2,226,000USD | -2,244,000USD |
| Sale Purchase Of Stock | -572,000USD | -1,730,000USD | -824,000USD | -864,000USD | -2,675,000USD | -1,026,000USD | -941,000USD | -972,000USD |
| Issuance Of Capital Stock | 0USD | 241,322,000USD | 138,760,000USD | 94,205,000USD | 37,084,000USD | 69,970,000USD | 0USD | 732,000USD |
| Change In Cash | -3,330,000USD | 44,191,000USD | -23,880,000USD | -17,720,000USD | -62,198,000USD | 90,151,000USD | -44,274,000USD | 18,725,000USD |
| Begin Period Cash Flow | 66,656,000USD | 22,465,000USD | 46,345,000USD | 64,065,000USD | 126,263,000USD | 36,112,000USD | 80,386,000USD | 61,661,000USD |
| End Period Cash Flow | 63,326,000USD | 66,656,000USD | 22,465,000USD | 46,345,000USD | 64,065,000USD | 126,263,000USD | 36,112,000USD | 80,386,000USD |
| Other Cashflows From Investing Activities | 3,712,000USD | 9,305,000USD | — | -69,752,000USD | 3,331,000USD | 171,398,000USD | -155,785,000USD | 169,671,000USD |
| Other Cashflows From Financing Activities | -572,000USD | 240,079,000USD | -49,943,000USD | -71,078,000USD | 11,700,000USD | 216,580,000USD | -2,226,000USD | 12,529,000USD |
| Unclassified Investing Cash Flow | -3,712,000USD | -8,274,000USD | 28,194,000USD | 69,752,000USD | -3,331,000USD | — | 155,785,000USD | -169,671,000USD |
| Dividends Paid | — | — | -99,922,000USD | — | -11,700,000USD | -216,580,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | 288,688,000USD | 165,283,000USD | 37,084,000USD | 69,970,000USD | 2,226,000USD | -11,797,000USD |
| Change To Liabilities | — | — | — | 76,000USD | -14,158,000USD | -20,969,000USD | -5,893,000USD | -42,853,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -17,720,000USD | -62,198,000USD | 90,151,000USD | -44,274,000USD | 18,725,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -6,014,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | License | 20,000,000 | USD | 0001062822-26-000101 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 1,090,000 | USD | 0001062822-26-000101 |
| FY 2025Yearly · 2025-12-31 | Product | License | 45,000,000 | USD | 0001062822-26-000050 |
| FY 2025Yearly · 2025-12-31 | Product | Other | 156,000 | USD | 0001062822-26-000050 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 4,647,000 | USD | 0001062822-26-000050 |
| Q3 2025Quarterly · 2025-09-30 | Product | License | 13,154,000 | USD | 0001062822-25-000054 |
| Q3 2025Quarterly · 2025-09-30 | Product | Other | 20,000 | USD | 0001062822-25-000054 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 1,008,000 | USD | 0001062822-25-000054 |
| Q2 2025Quarterly · 2025-06-30 | Product | License | 27,544,000 | USD | 0001628280-25-038340 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 1,322,000 | USD | 0001628280-25-038340 |
| Q1 2025Quarterly · 2025-03-31 | Product | License | 0 | USD | 0001062822-26-000101 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 1,262,000 | USD | 0001062822-26-000101 |
| FY 2024Yearly · 2024-12-31 | Product | License | 25,000,000 | USD | 0001062822-26-000050 |
| FY 2024Yearly · 2024-12-31 | Product | Other | 80,000 | USD | 0001062822-26-000050 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 6,001,000 | USD | 0001062822-26-000050 |
| Q3 2024Quarterly · 2024-09-30 | Product | License | 0 | USD | 0001062822-25-000054 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other | 9,000 | USD | 0001062822-25-000054 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 1,741,000 | USD | 0001062822-25-000054 |
| Q2 2024Quarterly · 2024-06-30 | Product | License | 0 | USD | 0001628280-25-038340 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other | 30,000 | USD | 0001628280-25-038340 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 1,617,000 | USD | 0001628280-25-038340 |
| FY 2023Yearly · 2023-12-31 | Product | License | 0 | USD | 0001062822-26-000050 |
| FY 2023Yearly · 2023-12-31 | Product | Other | 94,000 | USD | 0001062822-26-000050 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 1,110,000 | USD | 0001062822-26-000050 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.